Merck KGaA Open to Taking Part in ImClone Systems Incorporated Bid

September 30, 2008 |

1 min read

FRANKFURT (Reuters) - Merck KGaA would not bid for ImClone Systems Inc on its own, but may consider taking part in a potential approach for the U.S. drugmaker, Merck's Chief Executive Karl-Ludwig Kley said.

Mergers & acquisitions Europe

MORE ON THIS TOPIC

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration

Mergers & acquisitions

Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend

December 10, 2025

·

1 min read

·

Annalee Armstrong

Hands holding red circle. Sensing energy between palms. Concept of human relation, togetherness, partnership, connection, contact or network. Design for banner, flyer, poster, cover or brochure.

Japan

Japanese Pharmas Looking Beyond Borders for M&A to US, EU

December 10, 2025

·

7 min read

·

Dan Samorodnitsky

Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation

Obesity

After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B

December 9, 2025

·

2 min read

·

Dan Samorodnitsky